中文English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R
Issue 5
May  2011

Dendritic cells and hepatitis C

  • Published Date: 2011-05-20
  • Dendritic cells (DCs) are currently known as the most powerful antigen-presenting cells.In patients with HCV infection, dysfunction of DCs can cause persistent viral infection leading to chronicity of the disease.DCs have become an important research focus for HCV vaccination, and it will be an effective immunology method for the treatment of viral hepatitis C.In this review, we summarized the relationship of DCs in viral hepatitis C and its perspective in the role of treatment.

     

  • [1]Pachiadakis I, Pollara G, Chain BM, et al.Is hepatitis C virus infection of dendritic cells a mechanism facilitating viral persistence[J].Lancet Infect Dis, 2005, 5 (5) :296-304.
    [2]Groux H, Foumier N, Cottrez F.Role of dendritic cells in the generation of regulatory T cells[J].Semin Immunol, 2004, 6 (2) :99-106.
    [3]Onishi Y, Fehervari Z, Yamaguchi T, et al.Foxp3+natural resulatery T cells pmferentially form aggregates on dendritic cells in vitro and actively inhibit their maturation[J].Proc Natl Acad Sci, 2008, 105 (29) :10113-10118.
    [4]Kanto T, Hayashi N, Takehara T, et al.Impaired allostimulatory capacity of peripheral blood dendritic cells recovered from hepatitis C virus-infected individuals[J].J Immunol, 1999, 162 (9) :5584-5591.
    [5]Li W, Krishnadas DK, Kumar R, et al.Priming and stimulation of hepatitis C virus-specific CD4+and CD8+T cells against HCV antigens NS4, NS5a or NS5b from HCV-naive individuals:implications for prophylactic vaccine[J].Int Immunol, 2008, 20 (1) :89-104.
    [6]Amjad M, Abdel-Haq N, Faisal M, et al.Decreased interferon-alpha production and impaired regulatory function of plasmacytoid dendritic cells induced by the hepatitis C virus NS 5 protein[J].Microbiol Immunol, 2008, 52 (10) :499-507.
    [7]Bain C, Fatmi A, Zoulim F, et al.Impaired allostimulatory function of dendritic cells in chronic hepatitis C infection[J].Gastroenterology, 2001, 120 (33) :512-524.
    [8]李军, 冯志华, 聂青和, 等.人DC-SIGN真核表达载体的构建及在K-562细胞中的表达[J].肝脏, 2006, 11 (1) :24-27.
    [9]王敏, 王辉, 蒋小玲, 等.DC-SIGNR基因多态性与肝功能和HCV病毒载量的相关性[J].中国医师进修杂志, 2007, 30 (30) :3-5.
    [10]Auffermann-Gretzinger S, Keeffe EB, Levy S.Impaired dendritic cell maturation in patients with chronic, but not resolved, hepatitis C virus infection[J].Blood, 2001, 97 (18) :3171-3176.
    [11]Dolganiuc A, Kodys K, Kopasz A, et al.Hepatitis C virus core and nonstructural protein 3 proteins induce pro-and anti-inflammatory cytokines and inhibit tendritic cell differentiation[J].J Immunol, 2003, 170 (11) :5615-5624.
    [12]Zimmermann M, Flechsig C, La Monica N, et al.Hepatitis C virus core protein impairs in vitro priming of specific T cell responses by dendritic cells and hepatocytes[J].J Hepatol, 2008, 48 (1) :51-60.
    [13]Dolganiuc A, Paek E, Kodys K, et al.Myeloid den-dritic cells of patients with chronic HCV infection induce proliferation of regulatory T lymphocytes[J].Gastroenterology.2008, 135 (6) :2119-2127.
    [14]Lai WK, Curbishley SM, Goddard S, et al.Hepatitis C is associated with perturbation of intrahepatic myeloid and plasmacytoid dendritic cell function[J].J Hepatol, 2007, 47 (3) :338-347.
    [15]Klade CS, Wedemeyer H, Berg T, et al.Therapeutic vaccination of chronic hepatitis C nonresponder patients with the peptide vaccine IC41[J].Gastroenterology, 2008, 134 (5) :1385-1395.
    [16]Firbas C, Boehm T, Buerger V, et al.Immunogenicity and safety of different injection routes and schedules of IC41, a Hepatitis C virus (HCV) peptide vaccine[J].Vaccine, 2010, 28 (12) :2397-2407.
    [17]Chua BY, Eriksson EM, Brown LE, et al.A self-adj-uvanting lipopeptide-based vaccine candidate for the treatment of hepatitis C virus infection[J].Vaccine, 2008, 26 (37) :4866-4875.
    [18]Gowans EJ, Roberts S, Jones K, et al.A phase I clinical trial of dendritic cell immunotherapy in HCV-infected individuals[J].J Hepatol, 2010, 53 (4) :599-607.
    [19]Zabaleta A, Llopiz D, Arribillaga L, et al.Vaccination against hepatitis C virus with dendritic cells transduced with an adenovirus encoding NS3 protein[J].Mol Ther, 2008, 16 (1) :210-217.
    [20]Yu H, Babiuk LA, van Drunen Littel-van den Hurk S.Strategies for loading dendritic cells with hepatitis C NS5a antigen and inducing protective immunity[J].J Viral Hepat, 2008, 15 (6) :459-470.
    [21]Forde KA, Reddy KR.Hepatitis C virus infection and immunomodulatory therapies[J].Clin Liver Dis, 2009, 13 (3) :391-401.
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Article Metrics

    Article views (3306) PDF downloads(807) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return